Lyell Immunopharma Inc.

NASDAQ: LYEL · Real-Time Price · USD
10.62
-0.14 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
10.58
-0.38%
After-hours: Aug 15, 2025, 04:10 PM EDT

Lyell Immunopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-9.76 -41.5 -3.61K -131.61
PEG Ratio
-0.24 -1.59 128.34 -5.94
PS Ratio
54.87K 74.91K 202.49 3.53K
PB Ratio
8.74 14.87 20.58 40.41
P/FCF Ratio
-20.55 -58.53 -88.47 -195.96
P/OCF Ratio
-20.61 -59.49 -101.13 -297.63
OCF/S Ratio
-2.66K -1.26K -2 -11.85
Debt / Equity Ratio
0.15 0.10 0.08 0.07
Quick Ratio
7.06 16.07 17.59 13.40
Current Ratio
7.06 16.07 17.59 13.40
Asset Turnover
0.00 0.00 0.09 0.01
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.9 -0.36 -0.01 -0.31
Return on Assets
-0.7 -0.31 -0.01 -0.25
Return on Invested Capital
-0.79 -0.34 -0.01 -0.23
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.81 -0.36
Net Profit Margin
-5.62K -1.8K -0.06 -26.81
Pretax Profit Margin
-5.62K -1.8K -2.16 -23.49
Operating Profit Margin
-5.88K -1.9K -2.16 -20.17
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.29K -1.74K -1.97 -18.77